Cargando…

A clinician-nurse model to reduce early mortality and increase clinic retention among high-risk HIV-infected patients initiating combination antiretroviral treatment

BACKGROUND: In resource-poor settings, mortality is at its highest during the first 3 months after combination antiretroviral treatment (cART) initiation. A clear predictor of mortality during this period is having a low CD4 count at the time of treatment initiation. The objective of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Braitstein, Paula, Siika, Abraham, Hogan, Joseph, Kosgei, Rose, Sang, Edwin, Sidle, John, Wools-Kaloustian, Kara, Keter, Alfred, Mamlin, Joseph, Kimaiyo, Sylvester
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297518/
https://www.ncbi.nlm.nih.gov/pubmed/22340703
http://dx.doi.org/10.1186/1758-2652-15-7
Descripción
Sumario:BACKGROUND: In resource-poor settings, mortality is at its highest during the first 3 months after combination antiretroviral treatment (cART) initiation. A clear predictor of mortality during this period is having a low CD4 count at the time of treatment initiation. The objective of this study was to evaluate the effect on survival and clinic retention of a nurse-based rapid assessment clinic for high-risk individuals initiating cART in a resource-constrained setting. METHODS: The USAID-AMPATH Partnership has enrolled more than 140,000 patients at 25 clinics throughout western Kenya. High Risk Express Care (HREC) provides weekly or bi-weekly rapid contacts with nurses for individuals initiating cART with CD4 counts of ≤100 cells/mm(3). All HIV-infected individuals aged 14 years or older initiating cART with CD4 counts of ≤100 cells/mm(3 )were eligible for enrolment into HREC and for analysis. Adjusted hazard ratios (AHRs) control for potential confounding using propensity score methods. RESULTS: Between March 2007 and March 2009, 4,958 patients initiated cART with CD4 counts of ≤100 cells/mm(3). After adjusting for age, sex, CD4 count, use of cotrimoxazole, treatment for tuberculosis, travel time to clinic and type of clinic, individuals in HREC had reduced mortality (AHR: 0.59; 95% confidence interval: 0.45-0.77), and reduced loss to follow up (AHR: 0.62; 95% CI: 0.55-0.70) compared with individuals in routine care. Overall, patients in HREC were much more likely to be alive and in care after a median of nearly 11 months of follow up (AHR: 0.62; 95% CI: 0.57-0.67). CONCLUSIONS: Frequent monitoring by dedicated nurses in the early months of cART can significantly reduce mortality and loss to follow up among high-risk patients initiating treatment in resource-constrained settings.